The TITAN Study: Topical Infliximab for the Treatment of Advanced Corneal Melt and Ocular Surface Inflammation.

Bouhout S, Geoffrion D, Bostan C, Jabbour S, Robert MC

Open source

DOI
10.1016/j.xops.2026.101346
Published
2026 Oct
Container
Ophthalmology science
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.xops.2026.101346,
  title = {The TITAN Study: Topical Infliximab for the Treatment of Advanced Corneal Melt and Ocular Surface Inflammation.},
  author = {Bouhout S and Geoffrion D and Bostan C and Jabbour S and Robert MC},
  year = {2026},
  journal = {Ophthalmology science},
  doi = {10.1016/j.xops.2026.101346},
  url = {https://doi.org/10.1016/j.xops.2026.101346}
}

RIS

TY  - JOUR
TI  - The TITAN Study: Topical Infliximab for the Treatment of Advanced Corneal Melt and Ocular Surface Inflammation.
AU  - Bouhout S
AU  - Geoffrion D
AU  - Bostan C
AU  - Jabbour S
AU  - Robert MC
PY  - 2026
JO  - Ophthalmology science
DO  - 10.1016/j.xops.2026.101346
UR  - https://doi.org/10.1016/j.xops.2026.101346
ER  - 

APA

S, B., D, G., C, B., S, J., & MC, R. (2026). The TITAN Study: Topical Infliximab for the Treatment of Advanced Corneal Melt and Ocular Surface Inflammation.. Ophthalmology science. https://doi.org/10.1016/j.xops.2026.101346

Source records